UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Should Therapeutic Drug Monitoring for Monoclonal Antibodies Remain the Exception or Become the Norm?

Clinical pharmacology and therapeutics, 2016-09, Vol.100 (3), p.215-217

2016

Volltextzugriff (PDF)

Determination of GDC-0449, a small-molecule inhibitor of the Hedgehog signaling pathway, in human plasma by solid phase extraction-liquid chromatographic-tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010-03, Vol.878 (9), p.785-790

2010

Volltextzugriff (PDF)

Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study

Annals of oncology, 2015-02, Vol.26 (2), p.320-325

2015

Volltextzugriff (PDF)

A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance

Annals of oncology, 2005-12, Vol.16 (12), p.1968-1973

2005

Volltextzugriff (PDF)

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance

Journal of clinical oncology, 1992-10, Vol.10 (10), p.1635-1642

1992

Volltextzugriff (PDF)

Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

Cancer chemotherapy and pharmacology, 1997-06, Vol.40, p.S13-S19

1997

Volltextzugriff (PDF)

Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance

Journal of clinical oncology, 1994-04, Vol.12 (4), p.835-842

1994

Volltextzugriff (PDF)

Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia

Leukemia, 2002-05, Vol.16 (5), p.920-927

2002

Volltextzugriff (PDF)

A Phase I Single-Dose Trial of Gadolinium Texaphyrin (Gd-Tex), a Tumor Selective Radiation Sensitizer Detectable by Magnetic Resonance Imaging

Clinical cancer research, 1999-04, Vol.5 (4), p.739-745

1999

Volltextzugriff (PDF)

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance

Journal of clinical oncology, 1992-10, Vol.10 (10), p.1624-1634

1992

Volltextzugriff (PDF)

Pharmacological considerations in the modulation of multidrug resistance

European journal of cancer (1990), 1996-06, Vol.32 (6), p.1082-1088

1996

Volltextzugriff (PDF)

Clinical trials of modulation of multidrug resistance pharmacokinetic and pharmacodynamic considerations

Cancer, 1993-12, Vol.72 (S11), p.3502-3514

1993

Volltextzugriff (PDF)

A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C α, administered as a 21‐day infusion to patients with advanced ovarian carcinoma

Cancer, 2004-01, Vol.100 (2), p.321-326

2004

Volltextzugriff (PDF)

Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance

Cancer chemotherapy and pharmacology, 2000, Vol.45 (4), p.305-311

2000

Volltextzugriff (PDF)

A Phase I Trial of Doxorubicin, Paclitaxel, and Valspodar (PSC 833), a Modulator of Multidrug Resistance

Clinical cancer research, 2001-05, Vol.7 (5), p.1221-1229

2001

Volltextzugriff (PDF)

Adjuvant Intravesicular Pharmacotherapy for Superficial Bladder Cancer

JNCI : Journal of the National Cancer Institute, 1991-05, Vol.83 (10), p.682-694

1991

Volltextzugriff (PDF)

Primary leiomyosarcoma of the vagina. A case report and literature review

International journal of gynecological cancer, 2000-07, Vol.10 (4), p.340-347

2000

Volltextzugriff (PDF)

Stage T1 Bladder Cancer: Grade is the Primary Determinant for Risk of Muscle Invasion

The Journal of urology, 1991-07, Vol.146 (1), p.28-31

1991

Volltextzugriff (PDF)

Absolute Bioavailability and Absorption Characteristics of Aerosolized Tobramycin in Adults with Cystic Fibrosis

Journal of clinical pharmacology, 1994-03, Vol.34 (3), p.255-259

1994

Volltextzugriff (PDF)

Long-term results of irradiation for patients with progressive Graves' ophthalmopathy

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.766-774

2001

Volltextzugriff (PDF)

Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy

The Annals of pharmacotherapy, 1997-09, Vol.31 (9), p.1006-1008

1997

Volltextzugriff (PDF)

Transitional Cell Carcinoma of the Prostate in Patients Undergoing Radical Cystoprostatectomy

The Journal of urology, 1992-01, Vol.147 (1), p.92-95

1992

Volltextzugriff (PDF)

MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors

Hematology/oncology clinics of North America, 1995-04, Vol.9 (2), p.319

1995

Volltextzugriff (PDF)

A Graphic Nomogram for Warfarin Dosage Adjustment

Pharmacotherapy, 1999-04, Vol.19 (4), p.461-467

1999

Volltextzugriff (PDF)

Prediction of Valproate serum concentrations in adult psychiatric patients using Bayesian model estimations with NPEM2 population pharmacokinetic parameters

Therapeutic drug monitoring, 1999-06, Vol.21 (3), p.351-354

1999

Volltextzugriff (PDF)

1 – 25 von 495

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(436)
Mit Volltextzugriff
(401)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Should Therapeutic Drug Monitoring for Monoclonal Antibodies Remain the Exception or Become the Norm?

Determination of GDC-0449, a small-molecule inhibitor of the Hedgehog signaling pathway, in human plasma by solid phase extraction-liquid chromatographic-tandem mass spectrometry

Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study

A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance

Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance

Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia

A Phase I Single-Dose Trial of Gadolinium Texaphyrin (Gd-Tex), a Tumor Selective Radiation Sensitizer Detectable by Magnetic Resonance Imaging

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance

Pharmacological considerations in the modulation of multidrug resistance

Clinical trials of modulation of multidrug resistance pharmacokinetic and pharmacodynamic considerations

A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C α, administered as a 21‐day infusion to patients with advanced ovarian carcinoma

Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance

A Phase I Trial of Doxorubicin, Paclitaxel, and Valspodar (PSC 833), a Modulator of Multidrug Resistance

Adjuvant Intravesicular Pharmacotherapy for Superficial Bladder Cancer

Primary leiomyosarcoma of the vagina. A case report and literature review

Stage T1 Bladder Cancer: Grade is the Primary Determinant for Risk of Muscle Invasion

Absolute Bioavailability and Absorption Characteristics of Aerosolized Tobramycin in Adults with Cystic Fibrosis

Long-term results of irradiation for patients with progressive Graves' ophthalmopathy

Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy

Transitional Cell Carcinoma of the Prostate in Patients Undergoing Radical Cystoprostatectomy

MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors

A Graphic Nomogram for Warfarin Dosage Adjustment

Prediction of Valproate serum concentrations in adult psychiatric patients using Bayesian model estimations with NPEM2 population pharmacokinetic parameters

Suchergebnisse filtern